According to iBio's latest financial reports the company's current revenue (TTM ) is HK$1.35 Million. In 2023 the company made a revenue of HK$0.39 Million a decrease over the revenue in the year 2022 that were of HK$14.54 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 (TTM) | HK$1.36 M | 249.96% |
2023 | HK$0.39 M | -97.31% |
2022 | HK$14.54 M | 39.16% |
2021 | HK$10.44 M | -42.18% |
2020 | HK$18.07 M | 33.04% |
2019 | HK$13.58 M | 100.52% |
2018 | HK$6.77 M | 88.89% |
2017 | HK$3.58 M | -46.47% |
2016 | HK$6.69 M | -9.86% |
2015 | HK$7.43 M | -31.11% |
2014 | HK$10.78 M | 125.58% |
2013 | HK$4.78 M | -44.57% |
2012 | HK$8.62 M | 3.41% |
2011 | HK$8.34 M | |
2010 | N/A | -100% |
2009 | HK$3.59 M | -61.83% |
2008 | HK$9.42 M |